61 – 70 of 107
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations.
(
- Contribution to journal › Article
-
Mark
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients.
(
- Contribution to journal › Article
- 2009
-
Mark
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
(
- Contribution to journal › Article
-
Mark
Investigation of C/EBP alpha function in human (versus murine) myelopoiesis provides novel insight into the impact of CEBPA mutations in acute myelogenous leukemia (AML)
(
- Contribution to journal › Letter
-
Mark
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
(
- Contribution to journal › Scientific review
-
Mark
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
(
- Contribution to journal › Scientific review
-
Mark
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
(
- Contribution to journal › Article
-
Mark
The role of VEGF and a functional link between VEGF and p27(Kip1) in acute myeloid leukemia.
(
- Contribution to journal › Article
- 2008
-
Mark
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines
(
- Contribution to journal › Letter
-
Mark
The BCL-2 promoter (-938C > A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia
(
- Contribution to journal › Article